Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Schluesener

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
FEMS Immunology and Medical Microbiology|March 1, 1997
Protection against generalized autoimmunity of the nervous system (GANS), a novel animal model with combined features of EAE, EAN and EAU by a recombinant HIV-1 Tat37-72 peptide-based multiple T cell epitope vaccineH J Schluesener
Journal of Neuroscience Research|October 15, 1996
Protection against experimental nervous system autoimmune diseases by a human immunodeficiency virus-1 Tat peptide-based polyvalent vaccineH J Schluesener
Journal of Neuroimmunology|July 22, 1998
The disintegrin domain of ADAM 8 enhances protection against rat experimental autoimmune encephalomyelitis, neuritis and uveitis by a polyvalent autoantigen vaccineH J Schluesener
Journal of Neuroimmunology|April 1, 1990
Transforming growth factors type beta 1 and beta 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-gamma and tumor necrosis factor-alphaH J Schluesener
Autoimmunity|January 1, 1991
Transforming growth factors type beta inhibit multidrug transport in rat astrocyte cell linesH J Schluesener
Journal of Neuroimmunology|June 1, 1986
Inhibition of rat autoimmune T cell activation by monoclonal antibodiesH J Schluesener
Journal of Neuroimmunology|April 1, 1987
T cell line-mediated EAE: prevention and therapy by a monoclonal antibody specific for T lymphoblastsH J Schluesener
Journal of Neuroscience Research|February 1, 1991
Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type beta 1, beta 2, and beta 1.2H J Schluesener
Journal of Neuroimmunology|March 1, 1986
Recombinant interleukin 2 (IL-2) promotes T cell line-mediated neuroautoimmune diseaseH J Schluesener, H Lassmann
Cellular and Molecular Life Sciences : CMLS|October 31, 2006
Mammalian toll-like receptors: from endogenous ligands to tissue regenerationZ Zhang, H J Schluesener
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
FEMS Immunology and Medical Microbiology|March 1, 1997
Protection against generalized autoimmunity of the nervous system (GANS), a novel animal model with combined features of EAE, EAN and EAU by a recombinant HIV-1 Tat37-72 peptide-based multiple T cell epitope vaccineH J Schluesener
Journal of Neuroscience Research|October 15, 1996
Protection against experimental nervous system autoimmune diseases by a human immunodeficiency virus-1 Tat peptide-based polyvalent vaccineH J Schluesener
Journal of Neuroimmunology|July 22, 1998
The disintegrin domain of ADAM 8 enhances protection against rat experimental autoimmune encephalomyelitis, neuritis and uveitis by a polyvalent autoantigen vaccineH J Schluesener
Journal of Neuroimmunology|April 1, 1990
Transforming growth factors type beta 1 and beta 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-gamma and tumor necrosis factor-alphaH J Schluesener
Autoimmunity|January 1, 1991
Transforming growth factors type beta inhibit multidrug transport in rat astrocyte cell linesH J Schluesener
Journal of Neuroimmunology|June 1, 1986
Inhibition of rat autoimmune T cell activation by monoclonal antibodiesH J Schluesener
Journal of Neuroimmunology|April 1, 1987
T cell line-mediated EAE: prevention and therapy by a monoclonal antibody specific for T lymphoblastsH J Schluesener
Journal of Neuroscience Research|February 1, 1991
Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type beta 1, beta 2, and beta 1.2H J Schluesener
Journal of Neuroimmunology|March 1, 1986
Recombinant interleukin 2 (IL-2) promotes T cell line-mediated neuroautoimmune diseaseH J Schluesener, H Lassmann
Cellular and Molecular Life Sciences : CMLS|October 31, 2006
Mammalian toll-like receptors: from endogenous ligands to tissue regenerationZ Zhang, H J Schluesener
Pageof 10